Study to Assess Food Effect on Pharmacokinetics of Entinostat in Subjects With Breast Cancer or Non-Small Cell Lung Cancer
NCT01594398
Breast Cancer, Breast Diseases
Sarasota, Florida, United States
View Trial DetailsNCT Number: NCT01192919
Overview of treatment reality in patients with bronchial carcinoma requiring systemic treatment and being treated by office-based oncologists in Germany.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
The TLK is a prospective, longitudinal, nation wide cohort study that collects data on the treatment reality of patients with NSCLC and SCLC. At inclusion, data in patient characteristics, comorbidities, tumor characteristics, biomarker testing and previous treatments are collected. During the course of observation data on all systemic treatments, radiotherapies, surgeries, and outcome are documented. Patients are followed until death or for a maximum of 3 years.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 3 years per patient
iOMEDICO AG
Industry
Clinical Registry Describing Treatment Reality and Therapy Modalities of Patients With Lung Cancer (NSCLC, SCLC and Neuroendocrine Tumors) Requiring Therapy.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01594398
Breast Cancer, Breast Diseases
Sarasota, Florida, United States
View Trial DetailsNCT01999985
Bronchial Neoplasms, Carcinoma, Bronchogenic
Tampa, Florida, United States
View Trial DetailsNCT07085429
Bronchial Cancer, Bronchial Neoplasms
Montpellier, France
View Trial DetailsNCT00340405
Lung Cancer, Lung Diseases
Beijing, China
View Trial Details